Advertisement

Topics

Accent Therapeutics Announces Company Launch with $40 Million Series A Financing for Novel, Precision Cancer Treatments Targeting RNA-Modifying Proteins

05:00 EDT 18 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company establishes platform strategy to lead development of promising new precision therapies in the emerging field of epitranscriptomics Accent Therapeutics team publishes authoritative review of ...

Other Sources for this Article

Ten Bridge Communications
Tom Donovan, 857-559-3397
tom@tenbridgecommunications.com

NEXT ARTICLE

More From BioPortfolio on "Accent Therapeutics Announces Company Launch with $40 Million Series A Financing for Novel, Precision Cancer Treatments Targeting RNA-Modifying Proteins"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...